IRulya Therapeutics IRLA SEC Filings

NASDAQ IRLA
$33.78 +2.78 (+8.95%)
At close: Nov 9, 2026 · 4:00 PM EST
EDGAR Disclosures

SEC Filings

Source SEC EDGAR

Every SEC filing IRulya Therapeutics Inc. (IRLA) has made, as reported on EDGAR — annual and quarterly reports, current reports, insider transactions and ownership disclosures. Filter by form group, form type or period, and open any filing or its index directly.

Form Type
# Form Type Form Group Accession Date Filing Index
1144Insider Transaction0001628280-26-066751Oct 21, 2026 1:15 AM
23Insider Transaction0002159407-26-000002Oct 19, 2026 12:16 AM
33Insider Transaction0002159117-26-000002Oct 19, 2026 12:15 AM
43Insider Transaction0001930805-26-000004Oct 19, 2026 12:14 AM
53Insider Transaction0001662170-26-000002Oct 19, 2026 12:12 AM
63Insider Transaction0002159394-26-000002Oct 19, 2026 12:11 AM
73Insider Transaction0001233539-26-000003Oct 19, 2026 12:10 AM
88-KCurrent Report0001193125-26-424731Oct 19, 2026 4:49 PM
9SCHEDULE 13GBeneficial Ownership Report0001104659-26-115859Oct 14, 2026 12:38 AM
10SCHEDULE 13GBeneficial Ownership Report0001193125-26-421651Oct 14, 2026 12:00 AM
118-KCurrent Report0001193125-26-418538Oct 9, 2026 3:59 PM
12S-8Prospectus0001193125-26-418091Oct 8, 2026 1:26 AM
138-KCurrent Report0001193125-26-415730Oct 6, 2026 12:57 AM
14DEFA14AOthers0001193125-26-411262Oct 2, 2026 3:31 PM
158-KCurrent Report0001193125-26-411260Oct 2, 2026 3:30 PM
168-KCurrent Report0001193125-26-390652Sep 14, 2026 8:30 PM
178-KCurrent Report0001193125-26-382838Sep 4, 2026 12:30 PM
188-KCurrent Report0001193125-26-371389Aug 27, 2026 8:30 PM
19DEF 14AOthers0001193125-26-364220Aug 25, 2026 12:30 PM
20EFFECTOthers9999999995-26-002741Aug 24, 2026 4:15 AM
218-KCurrent Report0001193125-26-353141Aug 17, 2026 10:01 AM
22SCHEDULE 13GBeneficial Ownership Report0001193125-26-352966Aug 14, 2026 1:20 AM
23SCHEDULE 13GBeneficial Ownership Report0001104659-26-097291Aug 14, 2026 8:44 PM
2410-QQuarterly & Annual Report0001193125-26-352201Aug 14, 2026 8:05 PM
25SCHEDULE 13GBeneficial Ownership Report0001172661-26-003692Aug 14, 2026 6:05 PM
268-KCurrent Report0001193125-26-350568Aug 14, 2026 12:21 PM
27SCHEDULE 13GBeneficial Ownership Report0001172661-26-003433Aug 14, 2026 10:07 AM
28S-3Prospectus0001193125-26-333764Aug 5, 2026 10:30 AM
29SCHEDULE 13GBeneficial Ownership Report0002050709-26-000021Aug 4, 2026 7:06 PM
308-KCurrent Report0001193125-26-328784Jul 31, 2026 8:50 PM
31PRE 14AOthers0001193125-26-328777Jul 31, 2026 8:48 PM
32S-3Prospectus0001193125-26-328769Jul 31, 2026 8:45 PM
338-KCurrent Report0001193125-26-324786Jul 30, 2026 10:02 AM
348-KCurrent Report0001193125-26-285572Jun 26, 2026 8:31 PM
358-KCurrent Report0001193125-26-284089Jun 26, 2026 1:18 PM
364Insider Transaction0000912282-26-000832Jun 15, 2026 9:57 PM
374Insider Transaction0000912282-26-000830Jun 15, 2026 9:51 PM
384Insider Transaction0001346566-26-000004Jun 11, 2026 9:30 PM
393Insider Transaction0001346566-26-000003Jun 11, 2026 9:28 PM
408-KCurrent Report0001193125-26-267862Jun 11, 2026 9:06 PM
41DOthers0000912282-26-000811Jun 11, 2026 4:02 PM
42DOthers0000912282-26-000809Jun 11, 2026 4:01 PM
43SCHEDULE 13GBeneficial Ownership Report0001104659-26-072388Jun 10, 2026 8:38 PM
448-KCurrent Report0001193125-26-234858May 21, 2026 9:06 PM
458-KCurrent Report0001193125-26-228956May 18, 2026 8:20 PM
468-KCurrent Report0001193125-26-228133May 18, 2026 1:33 PM
47SCHEDULE 13GBeneficial Ownership Report0001104659-26-062688May 15, 2026 8:38 PM
4810-QQuarterly & Annual Report0001193125-26-217098May 11, 2026 9:09 PM
498-KCurrent Report0001193125-26-187243Apr 28, 2026 8:30 PM
50ARSOthers0001193125-26-182282Apr 27, 2026 8:42 PM
...

IRulya Therapeutics Inc. SEC Filings API

Pull IRulya Therapeutics Inc.'s SEC filing index, with links to every filing and exhibit, into your own tools with the Business Quant SEC Filings API. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/secfilings?ticker=IRLA&formtype=10-K,10-Q&api_key=YOUR_API_KEY